Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Fischer, Thomas
[Clear All Filters]
2023
Baur R
,
Karl F
,
Böttcher-Loschinski R
,
Stoll A
,
Völkl S
,
Gießl A
,
Flamann C
,
Bruns H
,
Schlötzer-Schrehardt U
,
Böttcher M
, et al.
Accumulation of T-cell-suppressive PD-L1 extracellular vesicles is associated with GvHD and might impact GvL efficacy.
J Immunother Cancer. 2023;11(3).
PubMed
Google Scholar
Ngai LLam
,
Hanekamp D
,
Janssen F
,
Carbaat-Ham J
,
Hofland MAM
,
Fayed MMHE
,
Kelder A
,
van Marsbergen LOudshoorn-
,
Scholten WJ
,
Snel AN
, et al.
Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial.
Blood. 2023.
PubMed
Google Scholar
Treiber H
,
Nilius-Eliliwi V
,
Seifert N
,
Vangala D
,
Wang M
,
Seidel S
,
Mika T
,
Marschner D
,
Zeremski V
,
Wurm-Kuczera R
, et al.
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.
Hemasphere. 2023;7(8):e926.
PubMed
Google Scholar
2022
Karl F
,
Liang C
,
Boettcher-Loschinski R
,
Stoll A
,
Flamann CSheree
,
Richter S
,
Lischer C
,
Völkl S
,
Jacobs B
,
Böttcher M
, et al.
Oxidative DNA Damage in Reconstituting T-cells is Associated with Relapse and Inferior Survival Following Allo-SCT.
Blood. 2022.
PubMed
Google Scholar
2021
Müller P
,
Baldauf CKatrin
,
Haage TRonny
,
Waldleben AMaria
,
Richter F
,
Pfizenmaier K
,
Fischer T
.
Anti-inflammatory treatment in MPN: Targeting TNFα-receptor 1 (TNFR1) and TNFR2 in JAK2-V617F induced disease.
Blood Adv. 2021.
PubMed
Google Scholar
Straka C
,
Salwender H
,
Knop S
,
Vogel M
,
Müller J
,
Metzner B
,
Langer C
,
Sayer H
,
Jung W
,
Dürk HA
, et al.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Eur J Haematol. 2021.
PubMed
Google Scholar
2014
Krüger WH
,
Hirt C
,
Basara N
,
Sayer HG
,
Behre G
,
Fischer T
,
Grobe N
,
Maschmeyer G
,
Niederwieser D
,
Dölken G
.
Allogeneic stem cell transplantation for mantle cell lymphoma-final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO).
Ann Hematol. 2014.
PubMed
Google Scholar